Shanghai Allist Pharmaceuticals Co. Ltd. Class ASSE: 688578

"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading

Jul 4, 2026 · Issued by Shanghai Allist Pharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Abnormal Fluctuations in Stock Trading

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Allist Pharmaceuticals Co. Ltd. Class A

Announcement on Implementation of Dividend Distribution for 2025May 26
Announcement on Resolutions of the 2025 Annual General MeetingMay 14
Announcement on Voluntary Disclosure of Obtaining of Approval Notice for the Drug Clinical Trial of Newly Approved Indication of Furmonertinib Mesylate TabletsApr 30
Notice on Convening the 2025 Annual General MeetingApr 23

All Shanghai Allist Pharmaceuticals Co. Ltd. Class A news releases